Weaver Consulting Group Edwards Lifesciences Corp Transaction History

Weaver Consulting Group

  • $287 Million
  • Q3 2024

A detailed history of Weaver Consulting Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Weaver Consulting Group holds 47,493 shares of EW stock, worth $3.55 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
47,493
Previous 47,852 0.75%
Holding current value
$3.55 Million
Previous $4.42 Million 29.1%
% of portfolio
1.09%
Previous 1.67%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$59.7 - $93.78 $21,432 - $33,667
-359 Reduced 0.75%
47,493 $3.13 Million
Q2 2024

Jul 12, 2024
BUY
$84.3 - $94.31 $708,120 - $792,204
8,400 Added 21.29%
47,852 $4.42 Million
Q1 2024

Apr 16, 2024
SELL
$72.54 - $95.56 $72,540 - $95,560
-1,000 Reduced 2.47%
39,452 $3.77 Million
Q4 2023

Jan 22, 2024
SELL
$61.71 - $77.76 $134,836 - $169,905
-2,185 Reduced 5.12%
40,452 $3.08 Million
Q3 2023

Oct 13, 2023
BUY
$69.28 - $93.38 $105,582 - $142,311
1,524 Added 3.71%
42,637 $2.95 Million
Q2 2023

Jul 19, 2023
SELL
$81.41 - $94.33 $162 - $188
-2 Reduced -0.0%
41,113 $3.88 Million
Q1 2023

Apr 11, 2023
SELL
$74.26 - $84.51 $74 - $84
-1 Reduced -0.0%
41,115 $3.4 Million
Q4 2022

Jan 09, 2023
BUY
$68.3 - $87.44 $106,957 - $136,931
1,566 Added 3.96%
41,116 $0
Q3 2022

Oct 04, 2022
BUY
$82.37 - $107.29 $6,260 - $8,154
76 Added 0.19%
39,550 $3.27 Million
Q2 2022

Jul 20, 2022
BUY
$86.5 - $128.27 $47,488 - $70,420
549 Added 1.41%
39,474 $3.75 Million
Q1 2022

May 06, 2022
BUY
$101.96 - $128.34 $20,392 - $25,668
200 Added 0.52%
38,925 $4.58 Million
Q4 2021

Feb 01, 2022
BUY
$106.37 - $130.68 $319 - $392
3 Added 0.01%
38,725 $5.02 Million
Q3 2021

Oct 28, 2021
BUY
$102.91 - $122.75 $12,143 - $14,484
118 Added 0.31%
38,722 $4.38 Million
Q2 2021

Jul 06, 2021
BUY
$83.84 - $104.76 $65,395 - $81,712
780 Added 2.06%
38,604 $4 Million
Q1 2021

Apr 07, 2021
BUY
$78.68 - $90.67 $117,547 - $135,460
1,494 Added 4.11%
37,824 $3.16 Million
Q4 2020

Jan 29, 2021
BUY
$71.69 - $91.23 $48,390 - $61,580
675 Added 1.89%
36,330 $3.31 Million
Q3 2020

Oct 28, 2020
BUY
$67.19 - $87.44 $105,824 - $137,718
1,575 Added 4.62%
35,655 $2.85 Million
Q2 2020

Jul 24, 2020
BUY
$57.54 - $76.95 $1.29 Million - $1.73 Million
22,499 Added 194.28%
34,080 $2.36 Million
Q1 2020

Apr 28, 2020
BUY
$52.41 - $81.0 $11,163 - $17,253
213 Added 1.87%
11,581 $2.18 Million
Q4 2019

Jan 31, 2020
BUY
$71.7 - $82.09 $32,623 - $37,350
455 Added 4.17%
11,368 $2.5 Million
Q2 2019

Aug 05, 2019
SELL
$55.74 - $64.41 $7,246 - $8,373
-130 Reduced 1.18%
10,913 $2.02 Million
Q1 2019

Jun 19, 2019
BUY
$47.89 - $64.05 $528,849 - $707,304
11,043 New
11,043 $2.05 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email